Cacti Therapeutics

Healing the Root of Chronic Pain

Founded 202227 employees

HealthcareMental Health & WellnessPharmaceuticals & MedicineBiotech

Capital FactoryAll Access Fund 2024

About

We are an early-stage pharmaceutical company creating novel therapies for chronic pain, inflammation and headache disorders.

Team

KS

Kaitlin Seymour Roberson

founder

See something off about this company?

Problem

Chronic pain is the #1 reason people seek healthcare. Our novel, non-addictive medicines and therapies aim to disrupt the $90 billion global market for pain pharmaceuticals.

Traction

Assembled a team of worldwide experts in AI drug development, plant medicine, pain neurobiology and psychiatry, each with a career focused on reducing human suffering. Our team has more than 25 years of combined training under Clifford Woolf, MD, PhD, the Harvard Med School professor who first described how chronic pain is driven by central sensitization.
Developed a transformative pharmaceutical development platform to address chronic pain by treating its physiological and psychological drivers.
Began biological proof of concept experiments with our patented, first-in-class analgesic compounds.

Links

Website LinkedIn

Share this profile

Sign in to see contact details

Pitch deck

Capital Factory Launch v4.pdf

1.8 MB · Uploaded Apr 23, 2026

This pitch deck is for investors.

Sign in to view →

Sign in to see more details